Summary:
The purpose of the trial is to compare the effectiveness and safety of semaglutide versus placebo in patients with type 2 diabetes, who are already treated with the medication SGLT-2 with or without the use of metformin.
Qualified Participants Must:
• Have Diabetes Type 2
•
Be over 18 years of age
•
Be treated with the medications called sodium-glucose cotransporter 2 (SGLT-2) inhibitors with or without sulfonylurea ( SU ) or metformin
Qualified Participants May Receive:
Reimbursement for time and travel